A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment alone.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony w badaniu hist-pat chłoniak rozlany z dużych komórek B (DLBCL).
- •Wynik badania obrazowego (PET) wskazujący na obecność choroby.
- •Brak wcześniejszego leczenia chłoniaka.
- •Ogólny stan zdrowia pacjenta pozwala na aktywne leczenie (oceniany według skali ECOG).
- •Prawidłowa praca serca (niezmieniona frakcja wyrzutowa).
- •Osoby zakażone wirusem HIV muszą mieć dobrze kontrolowane zakażenie wirusami.
- •Osoby zakażone wirusem zapalenia wątroby typu B (WZW B) kwalifikują się, jeśli przyjmują leki przeciwwirusowe i wirus jest niewykrywalny.
- •Osoby z przebytym zakażeniem wirusem zapalenia wątroby typu C (WZW C) kwalifikują się, jeśli wirus jest niewykrywalny.
✗ Disqualifies
- •Wcześniejsza historia przekształcenia się łagodniejszego nowotworu w DLBCL.
- •Diagnoza innego specyficznego typu chłoniaka (np. śródpiersiowy chłoniak z dużych komórek B).
- •Chłoniak w bardzo wczesnym stadium (Ann Arbor Stage I).
- •Istniejące poważne choroby serca (np. po zawale, udarze, niewydolność serca).
- •Aktywne płyny w jamie opłucnej lub osierdziu.
- •Istniejące lub rozwijające się uszkodzenie nerwów obwodowych (neuropatia).
- •Specyficzne choroby neurologiczne (np. demielinizacyjna forma choroby Charcota-Mariego-Tootha).
- •Zakażeni HIV z przebytą chorobą Kaposiego lub wieloogniskową chorobą Castlemana.
- •Obecnie przyjmowane leki sterydowe.
- •Przyjmowanie szczepionek zawierających żywe wirusy lub osłabione wirusy w ciągu ostatnich 30 dni.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (263)
Banner MD Anderson Cancer Center ( Site 0165)
Gilbert, United States
Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167)
Phoenix, United States
The University of Arizona Cancer Center - North Campus ( Site 0124)
Tucson, United States
Providence Medical Foundation-Oncology ( Site 0168)
Fullerton, United States
MemorialCare Health System - Long Beach Medical Center ( Site 9559)
Long Beach, United States
Cancer Blood and Specialty Clinic ( Site 0109)
Los Alamitos, United States
Cedars-Sinai Medical Center ( Site 0115)
Los Angeles, United States
Pacific Hematology Oncology Associates ( Site 0131)
San Francisco, United States
Lutheran Hospital - Cancer Centers of Colorado ( Site 0180)
Golden, United States
Clermont Oncology Center ( Site 0182)
Clermont, United States
Bioresearch Partner ( Site 0157)
Hialeah, United States
Orlando Health Cancer Institute ( Site 0169)
Ocoee, United States
Mid Florida Hematology and Oncology Center ( Site 0172)
Orange City, United States
Cancer Care Specialists of Illinois ( Site 0152)
O'Fallon, United States
Fort Wayne Medical Oncology and Hematology ( Site 0149)
Fort Wayne, United States
Cotton O'Neil Cancer Center ( Site 0108)
Topeka, United States
University of Kentucky ( Site 0106)
Lexington, United States
Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0163)
Louisville, United States
Owensboro Medical Health System ( Site 0195)
Owensboro, United States
CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0184)
Alexandria, United States
American Oncology Partners, P.A. ( Site 0185)
Bethesda, United States
Karmanos Cancer Institute ( Site 0174)
Detroit, United States
Corewell Health ( Site 0130)
Grand Rapids, United States
The University of Mississippi Medical Center ( Site 0161)
Jackson, United States
Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166)
Bridgeton, United States
Truman Medical Center ( Site 0122)
Kansas City, United States
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0178)
Billings, United States
OptumCare Cancer Care ( Site 0121)
Las Vegas, United States
Comprehensive Cancer Centers of Nevada ( Site 0113)
Las Vegas, United States
New York Oncology Hematology, P.C. ( Site 0129)
Albany, United States
Icahn School of Medicine at Mount Sinai ( Site 0164)
New York, United States
Sanford Health Roger Maris Cancer Center ( Site 0189)
Fargo, United States
Prisma Health - Upstate ( Site 0158)
Greenville, United States
Sanford Cancer Center ( Site 0143)
Sioux Falls, United States
The University of Tennessee Medical Center ( Site 0142)
Knoxville, United States
Center for Oncology and Blood Disorders ( Site 0153)
Houston, United States
Houston Methodist Cancer Center ( Site 0154)
Houston, United States
University of Virginia Cancer Center ( Site 0138)
Charlottesville, United States
Virginia Cancer Institute ( Site 0148)
Richmond, United States
Blue Ridge Cancer Care ( Site 0132)
Roanoke, United States
Vista Oncology ( Site 4201)
Olympia, United States
SSM Health Dean Medical Group ( Site 0140)
Madison, United States
Clinica Adventista Belgrano ( Site 0309)
Caba., Argentina
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0306)
Mar del Plata, Argentina
Hospital Universitario Austral ( Site 0307)
Pilar, Argentina
Hospital Aleman ( Site 0301)
Buenos Aires, Argentina
Fundacion Estudios Clinicos ( Site 0311)
Rosario, Argentina
C.I.C.E. 9 de Julio ( Site 0305)
San Miguel de Tucumán, Argentina
Hospital Italiano de Buenos Aires ( Site 0304)
CABA, Argentina
Clinica EL Castaño ( Site 0312)
San Juan, Argentina
Townsville University Hospital ( Site 3006)
Douglas, Australia
Royal Adelaide Hospital ( Site 3001)
Adelaide, Australia
Grampians Health ( Site 3003)
Ballarat, Australia
Northern Hospital ( Site 3002)
Melbourne, Australia
Royal Perth Hospital-Haematology ( Site 3004)
Perth, Australia
AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 1102)
Mechelen, Belgium
ASBL CHU Helora - Hôpital de Mons - Site Kennedy ( Site 1103)
Mons, Belgium
CEONC ( Site 0412)
Cascavel, Brazil
Hospital Erasto Gaertner ( Site 0401)
Curitiba, Brazil
Liga Norte Riograndense Contra o Cancer ( Site 0407)
Natal, Brazil
CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 0403)
Florianópolis, Brazil
Hope ( Site 0413)
Ribeirão Preto, Brazil
Clinica Advanze ( Site 0411)
São Carlos, Brazil
F. F. R. M. São Jose do Rio Preto ( Site 0404)
SJRP, Brazil
Hospital Paulistano ( Site 0406)
São Paulo, Brazil
Hospital das Clinicas FMUSP ( Site 0402)
São Paulo, Brazil
Cross Cancer Institute ( Site 0205)
Edmonton, Canada
Queen Elizabeth II Health Sciences Centre ( Site 0207)
Halifax, Canada
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208)
Hamilton, Canada
Lakeridge Health - The R.S. McLaughlin Durham Regional Cancer Centre (MDRCC) ( Site 0206)
Oshawa, Canada
Sunnybrook Research Institute ( Site 0204)
Toronto, Canada
Biocenter ( Site 0510)
Concepción, Chile
IC La Serena Research ( Site 0504)
La Serena, Chile
Oncocentro Valdivia ( Site 0506)
Valdivia, Chile
Centro de Estudios Clínicos SAGA ( Site 0508)
Santiago, Chile
FALP ( Site 0501)
Santiago, Chile
Clinica Inmunocel ( Site 0503)
Santiago, Chile
Clínica RedSalud Vitacura ( Site 0512)
Santiago, Chile
Bradfordhill ( Site 0502)
Santiago, Chile
Centro de Investigaciones ( Site 0511)
Viña del Mar, Chile
Anhui Provincial Cancer Hospital ( Site 3124)
Hefei, China
Peking University Third Hospital ( Site 3102)
Beijing, China
Beijing Cancer Hospital ( Site 3101)
Beijing, China
Chongqing Cancer Hospital ( Site 3113)
Chongqing, China
Fujian Provincial Cancer Hospital. ( Site 3119)
Fuzhou, China
The First Affiliated Hospital of Xiamen University ( Site 3120)
Xiamen, China
Sun Yat-sen University Cancer Center ( Site 3121)
Guangzhou, China
Zhujiang Hospital of Southern Medical University ( Site 3122)
Guangzhou, China
Affiliated Cancer Hospital of Guangxi Medical University ( Site 3123)
Nanning, China
The Affiliated Hospital of Guizhou Medical University ( Site 3112)
Guiyang, China
Hubei Cancer Hospital ( Site 3125)
Wuhan, China
Affiliated Hospital of Nantong University ( Site 3117)
Nantong, China
Jiangxi Cancer Hospital ( Site 3118)
Nanchang, China
The First Hospital Of Jilin University ( Site 3103)
Changchun, China
Shandong Cancer Hospital ( Site 3108)
Jinan, China
LinYi Cancer Hospital ( Site 3104)
Linyi, China
Fudan University Shanghai Cancer Center ( Site 3115)
Shanghai, China
Shanxi Cancer Hospital ( Site 3106)
Taiyuan, China
1st Affil Hosp of Med College of Xi'an Jiaotong University ( Site 3107)
Xi’an, China
Sichuan Cancer Hospital. ( Site 3111)
Chengdu, China
West China Hospital, Sichuan University ( Site 3110)
Chengdu, China
Institute of Hematology and Blood Diseases Hosp CAMS&PUMC ( Site 3105)
Tianjin, China
Yunnan Province Cancer Hospital ( Site 3109)
Kunming, China
The First Affiliated Hospital, Zhejiang Medical University ( Site 3116)
Hangzhou, China
Hospital Pablo Tobon Uribe ( Site 0604)
Medellín, Colombia
Hospital Universitario San Ignacio ( Site 0607)
Bogotá, Colombia
IMAT S.A.S ( Site 0603)
Montería, Colombia
Oncologos del Occidente ( Site 0601)
Pereira, Colombia
Fundación Valle del Lili ( Site 0602)
Cali, Colombia
University College Hospital, Department of Haematology ( Site 1303)
Aarhus, Denmark
Regionshospitalet Gødstrup ( Site 1301)
Herning, Denmark
Aalborg University Hospital ( Site 1302)
Aalborg, Denmark
Odense Universitetshospital ( Site 1304)
Odense, Denmark
Centre Antoine-Lacassagne ( Site 1514)
Nice, France
Hopital Saint Louis, Centre Hospitalier de La Rochelle ( Site 1511)
La Rochelle, France
CHU Dijon Bourgogne ( Site 1516)
Dijon, France
CHU GRENOBLE ALPES ( Site 1518)
La Tronche, France
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1512)
Limoges, France
Centre Hospitalier Régional Metz Thionville - Hôpital de Mercy ( Site 1515)
Metz, France
Centre Hospitalier de Dunkerque ( Site 1513)
Dunkirk, France
Centre Hospitalier Universitaire Estaing ( Site 1508)
Clermont-Ferrand, France
Centre Hospitalier de la Cote Basque ( Site 1509)
Bayonne, France
Centre Henri Becquerel ( Site 1517)
Rouen, France
HIA Sainte Anne ( Site 1506)
Toulon, France
Centre Hospitalier d'Avignon ( Site 1505)
Avignon, France
CHD Vendee ( Site 1502)
La Roche-sur-Yon, France
Institut Curie - site Saint-Cloud ( Site 1501)
Saint-Cloud, France
Evangelismos General Hospital of Athens ( Site 1602)
Athens, Greece
General Hospital of Athens "Laiko"-Hematology Department ( Site 1603)
Athens, Greece
Attikon University General Hospital of Athens ( Site 1604)
Athens, Greece
University General Hospital of Alexandroupoli ( Site 1601)
Alexandroupoli, Greece
MEDI-K ( Site 0701)
Guatemala City, Guatemala
CELAN,S.A ( Site 0702)
Guatemala City, Guatemala
Cen Integral Onco Gastro y Hemato Onco Guatemala S.A. ( Site 0703)
Guatemala City, Guatemala
Princess Margaret Hospital ( Site 3202)
Hong Kong, Hong Kong
Queen Mary Hospital ( Site 3201)
Hong Kong, Hong Kong
Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1703)
Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont ( Site 1702)
Debrecen, Hungary
Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1704)
Nyíregyháza, Hungary
Tolna Vármegyei Balassa János Kórház ( Site 1710)
Szekszárd, Hungary
Orszagos Onkologiai Intezet ( Site 1705)
Budapest, Hungary
Carmel Hospital ( Site 1903)
Haifa, Israel
Hadassah Medical Center ( Site 1901)
Jerusalem, Israel
Sourasky Medical Center ( Site 1904)
Tel Aviv, Israel
Poria Medical Center ( Site 1902)
Tiberias, Israel
Fondazione IRCCS San Gerardo dei Tintori ( Site 2008)
Monza, Italy
IRCCS Crob ( Site 2002)
Rionero in Vulture, Italy
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia ( Site 2010)
Candiolo, Italy
AOU delle Marche Ospedali Riuniti di Ancona ( Site 2011)
Ancona, Italy
Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 2001)
Brescia, Italy
IRCCS Ospedale San Raffaele ( Site 2012)
Milan, Italy
IEO Istituto Europeo di Oncologia ( Site 2009)
Milan, Italy
Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 2004)
Novara, Italy
Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO ( Site 2005)
Palermo, Italy
Ospedale Santa Maria delle Croci ( Site 2006)
Ravenna, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 2003)
Roma, Italy
Nagoya University Hospital ( Site 3309)
Nagoya, Japan
National Cancer Center Hospital East ( Site 3303)
Kashiwa, Japan
National Hospital Organization Shikoku Cancer Center ( Site 3321)
Matsuyama, Japan
Kobe City Medical Center General Hospital ( Site 3318)
Kobe, Japan
Kanazawa University Hospital ( Site 3308)
Kanazawa, Japan
Tokai University Hospital ( Site 3302)
Isehara, Japan
Tohoku University Hospital ( Site 3301)
Sendai, Japan
Kindai University Hospital ( Site 3310)
Sakai, Japan
Saitama Medical University Hospital ( Site 3305)
Iruma-gun, Japan
Juntendo University Hospital ( Site 3307)
Bunkyo, Japan
Tokyo Metropolitan Komagome Hospital ( Site 3323)
Bunkyo, Japan
University of Yamanashi Hospital ( Site 3320)
Chūō, Japan
Chiba Cancer Center ( Site 3314)
Chiba, Japan
Kyushu University Hospital ( Site 3313)
Fukuoka, Japan
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 3322)
Hiroshima, Japan
University Hospital,Kyoto Prefectural University of Medicine ( Site 3315)
Kyoto, Japan
University of Miyazaki Hospital ( Site 3319)
Miyazaki, Japan
Okayama University Hospital ( Site 3311)
Okayama, Japan
Osaka Metropolitan University Hospital ( Site 3317)
Osaka, Japan
Yamagata University Hospital ( Site 3312)
Yamagata, Japan
Queen Elizabeth Hospital ( Site 3405)
Kota Kinabalu, Malaysia
Sarawak General Hospital ( Site 3402)
Kuching, Malaysia
Hospital Miri ( Site 3403)
Miri, Malaysia
Sunway Medical Centre ( Site 3406)
Petaling Jaya, Malaysia
Hospital Ampang ( Site 3404)
Selangor Darul Ehsan, Malaysia
CIMAB SA de CV ( Site 0807)
Torreón, Mexico
Grupo Ollin Care ( Site 0806)
Pachuca, Mexico
Health Pharma Professional Research S.A. de C.V. ( Site 0801)
Mexico City, Mexico
Centro de Infusion Superare ( Site 0804)
Mexico City, Mexico
Centro de Investigacion Clinica Chapultepec ( Site 0803)
Morelia, Mexico
Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"" ( Site 0802)
Monterrey, Mexico
Centro de Investigacion Clinica de Oaxaca ( Site 0805)
Oaxaca City, Mexico
Albert Schweitzer Ziekenhuis ( Site 2103)
Dordrecht, Netherlands
Meander Medisch Centrum ( Site 2101)
Amersfoort, Netherlands
Clínicas AUNA Sede Chiclayo ( Site 0904)
Chiclayo, Peru
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0901)
Surquillo, Peru
Clínica San Felipe ( Site 0906)
Lima, Peru
Hospital Nacional Edgardo Rebagliati Martins ( Site 0903)
Lima, Peru
Hospital Nacional Dos De Mayo ( Site 0905)
Lima, Peru
Pratia Onkologia Wroclaw ( Site 2211)
Wroclaw, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2201)
Warsaw, Poland
Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 2210)
Słupsk, Poland
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2208)
Gliwice, Poland
Pratia Onkologia Katowice ( Site 2204)
Katowice, Poland
Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 2205)
Olsztyn, Poland
Unidade Local de Saude de Braga - Hospital de Braga ( Site 2306)
Braga, Portugal
Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 2308)
Lisbon, Portugal
Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2302)
Porto, Portugal
Auxilio Mutuo Cancer Center ( Site 1001)
San Juan, Puerto Rico
BRCR Global Puerto Rico - Caribbean Cancer Care ( Site 1003)
Yauco, Puerto Rico
Spitalul Clinic Colțea ( Site 2401)
Bucharest, Romania
Institutul Oncologic Cluj ( Site 2404)
Cluj-Napoca, Romania
Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 2402)
Brasov, Romania
Spital Judetean Sibiu ( Site 2405)
Sibiu, Romania
National University Hospital ( Site 3702)
Singapore, Singapore
National Cancer Centre Singapore ( Site 3701)
Singapore, Singapore
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2506)
Pretoria, South Africa
Netcare Pretoria East Hospital ( Site 2502)
Pretoria, South Africa
Haemalife ( Site 2501)
Cape Town, South Africa
Groote Schuur Hospital ( Site 2504)
Cape Town, South Africa
National Cancer Center- Center for Hemotologic malignancy ( Site 3806)
Goyang-si, South Korea
Pusan National University Hospital ( Site 3804)
Busan, South Korea
Chungnam National University Hospital ( Site 3801)
Daejeon, South Korea
Severance Hospital, Yonsei University Health System ( Site 3802)
Seoul, South Korea
Asan Medical Center ( Site 3803)
Seoul, South Korea
Samsung Medical Center ( Site 3807)
Seoul, South Korea
St.Mary's H., Youido ( Site 3805)
Seoul, South Korea
Hospital Universitario Virgen Macarena ( Site 2608)
Seville, Spain
ICO L Hospitalet ( Site 2601)
L'Hospitalet de Llobregat, Spain
H. Insular de Gran Canaria ( Site 2606)
Las Palmas de Gran Canaria, Spain
Hospital Universitario Puerta de Hierro ( Site 2615)
Majadahonda, Spain
Hospital de Cabuenes ( Site 2613)
Gijón, Spain
Hospital General Universitario Dr. Balmis ( Site 2604)
Alicante, Spain
Hospital del Mar ( Site 2610)
Barcelona, Spain
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 2614)
Madrid, Spain
Hospital General Universitario 12 de Octubre ( Site 2605)
Madrid, Spain
Hospital Universitario La Paz ( Site 2611)
Madrid, Spain
Hospital Virgen de la Victoria ( Site 2609)
Málaga, Spain
Hospital Universitario Miguel Servet ( Site 2607)
Zaragoza, Spain
Kantonspital Baden ( Site 2703)
Baden, Switzerland
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2702)
Sankt Gallen, Switzerland
Ospedale Regionale Bellinzona e Valli ( Site 2701)
Bellinzona, Switzerland
Ospedale Italiano Lugano (OIL) ( Site 2705)
Lugano, Switzerland
Chang Gung Memorial Hospital - Linkou Branch ( Site 3903)
Taoyuan City, Taiwan
Chang Gung Memorial Hospital at Kaohsiung ( Site 3905)
Kaohsiung City, Taiwan
National Cheng Kung University Hospital ( Site 3902)
Tainan, Taiwan
National Taiwan University Hospital ( Site 3901)
Taipei, Taiwan
Mackay Memorial Hospital ( Site 3908)
Taipei, Taiwan
Tri-Service General Hospital ( Site 3906)
Taipei, Taiwan
Faculty of Medicine Siriraj Hospital ( Site 4001)
Bangkoknoi, Thailand
Chulalongkorn University ( Site 4003)
Pathumwan, Thailand
Maharaj Nakorn Chiang Mai Hospital ( Site 4002)
Muang, Thailand
Ondokuz Mayıs Universitesi ( Site 2806)
Korfez Mahallesi, Turkey (Türkiye)
Namık Kemal University Medical Faculty ( Site 2807)
Suleymanpasa, Turkey (Türkiye)
Baskent Universitesi Adana Dr. Turgut Noyan UAM ( Site 2809)
Adana, Turkey (Türkiye)
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 2803)
Ankara, Turkey (Türkiye)
Hacettepe Universite Hastaneleri ( Site 2810)
Ankara, Turkey (Türkiye)
Ankara University Faculty of Medicine ( Site 2801)
Ankara, Turkey (Türkiye)
Antalya Egitim ve Arastirma Hastanesi ( Site 2805)
Antalya, Turkey (Türkiye)
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi ( Site 2804)
Istanbul, Turkey (Türkiye)
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2904)
Cherkasy, Ukraine
Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 2906)
Ivano-Frankivsk, Ukraine
Khmelnytskyi Regional Hospital ( Site 2907)
Khmelnytskiy, Ukraine
Institute of Blood Pathology and Transfusion Medicine AMS Ukraine ( Site 2903)
Lviv, Ukraine
SNPE National Cancer Institute ( Site 2902)
Kyiv, Ukraine
Universal Clinic Oberig ( Site 2908)
Kyiv, Ukraine
SI National Research Center of Radiation Medicine, Hematology, Oncology ( Site 2901)
Kyiv, Ukraine
Trial contact
Toll Free Number
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.